In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Magdalena Tagowska Ph.D. in IAM Patent 1000 ranking!

Congratulations to Magdalena Tagowska Ph.D. who received an individual award in the prosecution category in Czytaj dalej

Patpol with another Managing IP recommendation!

We are delighted to have been honored also this year in the international IP STARS Czytaj dalej

Let?s look at the sky and we?ll find an invention So how is it with the inventions? [Article on IP-Blog.pl]

Author: Olimpia Misztal, assistant in Patent Department On the 14th April, every year, in the calendar Czytaj dalej